Wang Y - Search Results

1

Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1.

Liang F, Wang GZ, Wang Y, Yang YN, Wen ZS, Chen DN, Fang WF, Zhang B, Yang L, Zhang C, Han SC, Yang FY, Wang D, Liang LJ, Wang Z, Zhao Y, Wang CL, Zhang L, Zhou GB. Liang F, et al. Among authors: wang z, wang y, wang gz, wang d, wang cl. Signal Transduct Target Ther. 2022 Sep 7;7(1):311. doi: 10.1038/s41392-022-01127-3. Signal Transduct Target Ther. 2022. PMID: 36068203 Free PMC article.

2

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes.

Zhang L, MacIsaac KD, Zhou T, Huang PY, Xin C, Dobson JR, Yu K, Chiang DY, Fan Y, Pelletier M, Wang Y, Jaeger S, Krishnamurthy Radhakrishnan V, JeBailey L, Skewes-Cox P, Zhang J, Fang W, Huang Y, Zhao H, Zhao Y, Li E, Peng B, Huang A, Dranoff G, Hammerman PS, Engelman J, Bitter H, Zeng YX, Yao Y. Zhang L, et al. Among authors: wang y. Mol Cancer Res. 2017 Dec;15(12):1722-1732. doi: 10.1158/1541-7786.MCR-17-0134. Epub 2017 Aug 29. Mol Cancer Res. 2017. PMID: 28851814

3

Concomitant Genetic Alterations With Response to Treatment and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With EGFR-Mutant Advanced Non-Small Cell Lung Cancer.

Hong S, Gao F, Fu S, Wang Y, Fang W, Huang Y, Zhang L. Hong S, et al. Among authors: wang y. JAMA Oncol. 2018 May 1;4(5):739-742. doi: 10.1001/jamaoncol.2018.0049. JAMA Oncol. 2018. PMID: 29596544 Free PMC article.

4

Favorable predictors for survival in advanced ALK-positive non-small cell lung cancer patients beyond crizotinib resistance.

Xu H, Yang G, Yang L, Yang Y, Ma D, Li J, Hao X, Xing P, Wang Y. Xu H, et al. Among authors: wang y. Thorac Cancer. 2019 May;10(5):1096-1102. doi: 10.1111/1759-7714.13050. Epub 2019 Mar 28. Thorac Cancer. 2019. PMID: 30920172 Free PMC article.

5

Sequential therapy according to distinct disease progression patterns in advanced ALK-positive non-small-cell lung cancer after crizotinib treatment.

Xu H, Ma D, Yang G, Li J, Hao X, Xing P, Yang L, Xu F, Wang Y. Xu H, et al. Among authors: wang y. Chin J Cancer Res. 2019 Apr;31(2):349-356. doi: 10.21147/j.issn.1000-9604.2019.02.09. Chin J Cancer Res. 2019. PMID: 31156305 Free PMC article.

6

The value of blood biomarkers of progression and prognosis in ALK-positive patients with non-small cell lung cancer treated with crizotinib.

Yang Y, Xu H, Yang G, Yang L, Li J, Wang Y. Yang Y, et al. Among authors: wang y. Asia Pac J Clin Oncol. 2020 Feb;16(1):63-69. doi: 10.1111/ajco.13284. Epub 2019 Nov 12. Asia Pac J Clin Oncol. 2020. PMID: 31721468

7

Routine-Dose and High-Dose Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 21-L858R Mutation: the Randomized, Phase II, INCREASE Trial.

Li X, Zhang L, Jiang D, Wang Y, Zang A, Ding C, Zhao M, Su W, Zhang Y, Zhong D, Wu J, Zhang C, An G, Hu X, Cheng G, Wang H, Li Y, He X, Liu J, Liang L, Ding L, Mao L, Zhang S. Li X, et al. Among authors: wang h, wang y. Clin Cancer Res. 2020 Jul 1;26(13):3162-3171. doi: 10.1158/1078-0432.CCR-19-3064. Epub 2020 Feb 14. Clin Cancer Res. 2020. PMID: 32060099 Clinical Trial.

8

[Explore the Optimal Resolvent of Medical Needs and Mental Health for Patients with Lung Cancer during Epidemic Novel Coronavirus Pneumonia].

Xu H, Yang K, Yang G, Yang L, Mi Y, Cui X, Yang M, Wang D, Wang Y. Xu H, et al. Among authors: wang y, wang d. Zhongguo Fei Ai Za Zhi. 2020 Apr 20;23(4):247-254. doi: 10.3779/j.issn.1009-3419.2020.101.18. Zhongguo Fei Ai Za Zhi. 2020. PMID: 32316712 Free PMC article. Chinese.

9

EGFR exon 20 insertion mutations in Chinese advanced non-small cell lung cancer patients: Molecular heterogeneity and treatment outcome from nationwide real-world study.

Yang G, Li J, Xu H, Yang Y, Yang L, Xu F, Xia B, Zhu VW, Nagasaka M, Yang Y, Li Y, Qiu W, Ying J, Ou SI, Wang Y. Yang G, et al. Among authors: wang y. Lung Cancer. 2020 Jul;145:186-194. doi: 10.1016/j.lungcan.2020.03.014. Epub 2020 Mar 18. Lung Cancer. 2020. PMID: 32336530

10

Apatinib in combination with pemetrexed-platinum chemotherapy for chemo-naive non-squamous non-small cell lung cancer: a phase II clinical study.

Yang G, Xu H, Yang L, Xu F, Zhang S, Yang Y, Wang Y. Yang G, et al. Among authors: wang y. Lung Cancer. 2020 Sep;147:229-236. doi: 10.1016/j.lungcan.2020.07.024. Epub 2020 Jul 23. Lung Cancer. 2020. PMID: 32739743 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

271,970 results

Search Page